Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-10-02 00:00:00 ET · period of report 2024-09-30 · accession 0000950170-24-111702 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-10-02 | 2024-09-30 | TYRA | Harris Todd | Pres, CEO, Dir | S - Sale | $24.00 | -500 | 1.48M | -0.0% | -$12.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-30 | S | D | 500 | $24.00 | 1,477,373 | D | — | — |